These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 24771612)
1. Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer. Wang PW; Abedini MR; Yang LX; Ding AA; Figeys D; Chang JY; Tsang BK; Shieh DB Int J Cancer; 2014 Dec; 135(12):2760-9. PubMed ID: 24771612 [TBL] [Abstract][Full Text] [Related]
2. Cell fate regulation by gelsolin in human gynecologic cancers. Abedini MR; Wang PW; Huang YF; Cao M; Chou CY; Shieh DB; Tsang BK Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14442-7. PubMed ID: 25246592 [TBL] [Abstract][Full Text] [Related]
3. Role of neurofilament light polypeptide in head and neck cancer chemoresistance. Chen B; Chen J; House MG; Cullen KJ; Nephew KP; Guo Z Mol Cancer Res; 2012 Mar; 10(3):305-15. PubMed ID: 22246235 [TBL] [Abstract][Full Text] [Related]
4. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer. Roh JL; Park JY; Kim EH; Jang HJ; Kwon M Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904 [TBL] [Abstract][Full Text] [Related]
5. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Asselin E; Mills GB; Tsang BK Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739 [TBL] [Abstract][Full Text] [Related]
6. XIAP is a predictor of cisplatin-based chemotherapy response and prognosis for patients with advanced head and neck cancer. Yang XH; Feng ZE; Yan M; Hanada S; Zuo H; Yang CZ; Han ZG; Guo W; Chen WT; Zhang P PLoS One; 2012; 7(3):e31601. PubMed ID: 22403616 [TBL] [Abstract][Full Text] [Related]
7. Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer. Kim EH; Jang H; Shin D; Baek SH; Roh JL Apoptosis; 2016 Nov; 21(11):1265-1278. PubMed ID: 27544755 [TBL] [Abstract][Full Text] [Related]
8. RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems. Shin D; Kim EH; Lee J; Roh JL Redox Biol; 2017 Oct; 13():219-227. PubMed ID: 28582730 [TBL] [Abstract][Full Text] [Related]
9. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation. Checinska A; Hoogeland BS; Rodriguez JA; Giaccone G; Kruyt FA Exp Cell Res; 2007 Apr; 313(6):1215-24. PubMed ID: 17291493 [TBL] [Abstract][Full Text] [Related]
10. Targeting acid ceramidase sensitises head and neck cancer to cisplatin. Roh JL; Park JY; Kim EH; Jang HJ Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835 [TBL] [Abstract][Full Text] [Related]
11. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma. Ma JJ; Chen BL; Xin XY Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis and chemoresistance in human ovarian cancer: is Xiap a determinant? Li J; Sasaki H; Sheng YL; Schneiderman D; Xiao CW; Kotsuji F; Tsang BK Biol Signals Recept; 2000; 9(2):122-30. PubMed ID: 10810207 [TBL] [Abstract][Full Text] [Related]
13. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis. Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681 [TBL] [Abstract][Full Text] [Related]
14. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer. Roh JL; Kim EH; Jang HJ; Park JY; Shin D Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897 [TBL] [Abstract][Full Text] [Related]
15. Hederagenin Induces Apoptosis in Cisplatin-Resistant Head and Neck Cancer Cells by Inhibiting the Nrf2-ARE Antioxidant Pathway. Kim EH; Baek S; Shin D; Lee J; Roh JL Oxid Med Cell Longev; 2017; 2017():5498908. PubMed ID: 29456786 [TBL] [Abstract][Full Text] [Related]
16. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells. Yang X; Xing H; Gao Q; Chen G; Lu Y; Wang S; Ma D Gynecol Oncol; 2005 May; 97(2):413-21. PubMed ID: 15863139 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Glucosylceramide Synthase Sensitizes Head and Neck Cancer to Cisplatin. Roh JL; Kim EH; Park JY; Kim JW Mol Cancer Ther; 2015 Aug; 14(8):1907-15. PubMed ID: 26063766 [TBL] [Abstract][Full Text] [Related]
18. XIAP-mediated protection of H460 lung cancer cells against cisplatin. Cheng YJ; Jiang HS; Hsu SL; Lin LC; Wu CL; Ghanta VK; Hsueh CM Eur J Pharmacol; 2010 Feb; 627(1-3):75-84. PubMed ID: 19903469 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of XIAP expression induces apoptosis and enhances chemotherapeutic sensitivity in human gastric cancer cells. Tong QS; Zheng LD; Wang L; Zeng FQ; Chen FM; Dong JH; Lu GC Cancer Gene Ther; 2005 May; 12(5):509-14. PubMed ID: 15706355 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly. Zhang X; Huang L; Zhao Y; Tan W Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]